ML11229A081: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
(Created page by program invented by StriderTol)
Line 16: Line 16:


=Text=
=Text=
{{#Wiki_filter:* File created using WinMACCS version 3.4.5 10/29/2009 5:21:34 PM *
{{#Wiki_filter:NIA-089
* DCF_FILE - Identifies the DCF file to be used for the MACCS calculation DCF_FILE001 'f:\NBixler\WinMACCS Projects\IndianPointPalla\Data\DOSDATA.INP'
* File created using WinMACCS version 3.4.5 10/29/2009 5:21:34 PM
*
*
* EANAM1 - Identifies the EARLY calculation MIEANAM1001 'EARLY.IN, IPEC INPUT FROM THE EVACUATION TIME ESTIMATES'  
* DCF_FILE - Identifies the DCF file to be used for the MACCS calculation DCF_FILE001 'f:\NBixler\WinMACCS Projects\IndianPointPalla\Data\DOSDATA.INP'
*
*
* ENDAT2 - control flag allowing execution of ATMOS and EARLY without CHRONC MIENDAT2001 .FALSE.  
* EANAM1 - Identifies the EARLY calculation MIEANAM1001 'EARLY.IN, IPEC INPUT FROM THE EVACUATION TIME ESTIMATES'
*
*
* IPLUME - dispersion code option MIIPLUME001 2
* ENDAT2 - control flag allowing execution of ATMOS and EARLY without CHRONC MIENDAT2001 .FALSE.
*
*
* NUMFIN - number of fine-grid subdivisions used by model MINUMFIN001 7 *
* IPLUME - dispersion code option MIIPLUME001 2
* IPRINT - amount of output desired MIIPRINT001 0  
*
* NUMFIN - number of fine-grid subdivisions used by model MINUMFIN001 7
*
* IPRINT - amount of output desired MIIPRINT001 0
*
*
* POPFLG - is population uniform or defined by Site Data File.
* POPFLG - is population uniform or defined by Site Data File.
PDPOPFLG001 FILE  
PDPOPFLG001 FILE
*
*
* ORGNAM_DOSFAC, ORGFLG_DOSFAC - list of organs to be included in the calculations using DOSFAC DCF file MIORGDEF001 A-SKIN .TRUE. MIORGDEF002  
* ORGNAM_DOSFAC, ORGFLG_DOSFAC - list of organs to be included in the calculations using DOSFAC DCF file MIORGDEF001 A-SKIN .TRUE.
'A-RED MARR' .TRUE. MIORGDEF003 A-LUNGS .TRUE.
MIORGDEF002 'A-RED MARR' .TRUE.
MIORGDEF003 A-LUNGS               .TRUE.
MIORGDEF004 A-THYROIDH .TRUE.
MIORGDEF004 A-THYROIDH .TRUE.
MIORGDEF005 A-STOMACH .TRUE.
MIORGDEF005 A-STOMACH .TRUE.
MIORGDEF006  
MIORGDEF006 'A-LOWER LI' .FALSE.
'A-LOWER LI' .FALSE. MIORGDEF007 L-EDEWBODY .TRUE.
MIORGDEF007 L-EDEWBODY .TRUE.
MIORGDEF008  
MIORGDEF008 'L-RED MARR' .TRUE.
'L-RED MARR' .TRUE. MIORGDEF009  
MIORGDEF009 'L-BONE SUR' .TRUE.
'L-BONE SUR' .TRUE.
MIORGDEF010 L-BREAST             .TRUE.
MIORGDEF010 L-BREAST .TRUE. MIORGDEF011 L-LUNGS .TRUE.
MIORGDEF011 L-LUNGS               .TRUE.
MIORGDEF012 L-THYROID .TRUE.
MIORGDEF012 L-THYROID             .TRUE.
MIORGDEF013  
MIORGDEF013 'L-LOWER LI' .TRUE.
'L-LOWER LI' .TRUE. MIORGDEF014  
MIORGDEF014 'L-BLAD WAL' .TRUE.
'L-BLAD WAL' .TRUE. MIORGDEF015 L-LIVER .FALSE.
MIORGDEF015 L-LIVER .FALSE.
MIORGDEF016 L-THYROIDH .TRUE.  
MIORGDEF016 L-THYROIDH           .TRUE.
*
* RISCAT - Output relative contribution of each weather category bins MIRISCAT001 .FALSE.
*
*
* RISCAT - Output relative contribution of each weather category bins MIRISCAT001 .FALSE.  
* OVRRID - Flag indicating if Wind Rose defaults from ATMOS are to be overridden MIOVRRID001 .FALSE.
* NIA-089
* CSFACT - Cloudshine shielding factor SECSFACT001 1.
SECSFACT002 0.75 SECSFACT003 0.6
*
*
* OVRRID - Flag indicating if Wind Rose defaults from ATMOS are to be overridden MIOVRRID001 .FALSE. *
* PROTIN - Inhalation protection factor SEPROTIN001 1.
* CSFACT - Cloudshine shielding factor SECSFACT001
SEPROTIN002 0.41 SEPROTIN003 0.33
: 1. SECSFACT002 0.75 SECSFACT003 0.6
*
*
* PROTIN - Inhalation protection factor SEPROTIN001
* BRRATE - Breathing rates SEBRRATE001 2.66E-4 SEBRRATE002 2.66E-4 SEBRRATE003 2.66E-4
: 1. SEPROTIN002 0.41 SEPROTIN003 0.33
*
*
* BRRATE - Breathing rates SEBRRATE001 2.66E-4 SEBRRATE002 2.66E-4 SEBRRATE003 2.66E-4 *
* SKPFAC - skin protection factors SESKPFAC001 1.0 SESKPFAC002 0.41 SESKPFAC003 0.33
* SKPFAC - skin protection factors SESKPFAC001 1.0 SESKPFAC002 0.41 SESKPFAC 003 0.33 *
*
* GSHFAC - groundshine shielding factors SEGSHFAC001 0.5 SEGSHFAC002 0.4 SEGSHFAC003 0.2  
* GSHFAC - groundshine shielding factors SEGSHFAC001 0.5 SEGSHFAC002 0.4 SEGSHFAC003 0.2
*
* RESCON - Initial value for emergency-phase resuspension concentration factor.
SERESCON001 1.E-4
*
*
* RESCON - Initial value for emergency-phase resuspension concentration factor. SERESCON001 1.E-4 *
* RESHAF - Emergency-phase resuspension concentration coefficient weathering half-life.
* RESHAF - Emergency-phase resuspension concentration coefficient weathering half-life.
SERESHAF001 1.82E5  
SERESHAF001 1.82E5
*
* EANAM2 - Name of emergency response scenario EZEANAM2001 'NO EVACUATION, RELOCATION MODELS APPLY EVERYWHE'
*
* WTNAME - type of weighting factor to be used in generating weighted sum of results EZWTNAME001 PEOPLE
*
* WTFRAC - weighting fraction applied to results of emergency response scenario EZWTFRAC001 1.00
*
* LASMOV2 (used for no evacuation), always 0 EZLASMOV001 0
*
*
* EANAM2 - Name of emergency response scenario EZEANAM2001 'NO EVACUATION, RELOCATION MODELS APPLY EVERYWHE'
* ENDEMP - duration of the emergency-phase period, seconds SRENDEMP001 604800.
*
*
* WTNAME - type of weighting factor to be used in generating weighted sum of results EZWTNAME001 PEOPLE *
* CRIORG - critical organ for relocation decisions during emergency-phase period SRCRIORG001 L-EDEWBODY
* WTFRAC - weighting fraction applied to results of emergency response scenario EZWTFRAC001 1.00 *
 
* LASMOV2  (used for no evacuation), always 0 EZLASMOV001 0
NIA-089
*
*
* ENDEMP - duration of the emergency-phase period, seconds SRENDEMP001 604800. *
* TIMHOT - hot-spot relocation action time, seconds after plume arrival SRTIMHOT001 43200.
* CRIORG - critical organ for relocation decisions during emergency-phase period SRCRIORG001 L-EDEWBODY 
*
*
* TIMHOT - hot-spot relocation action time, seconds after plume arrival SRTIMHOT001 43200.  
* TIMNRM - Normal Relocation Time (Seconds from Plume Arrival)
SRTIMNRM001 86400.
*
*
* TIMNRM - Normal Relocation Time (Seconds from Plume Arrival) SRTIMNRM001 86400. *
* DOSHOT - Hot-Spot Relocation Dose Threshold (Sieverts)
* DOSHOT - Hot-Spot Relocation Dose Threshold (Sieverts)
SRDOSHOT001 0.5  
SRDOSHOT001 0.5
*
*
* DOSNRM - Normal Relocation Dose Threshold (Sieverts)
* DOSNRM - Normal Relocation Dose Threshold (Sieverts)
SRDOSNRM001 0.25  
SRDOSNRM001 0.25
*
* NUMEFA - Number of Early Fatality Effects EFNUMEFA001 2
*
*
* NUMEFA - Number of Early Fatality Effects EFNUMEFA001 2 *
* ORGNAM2, EFFACA, EFFACB, EFFTHR Early Fatality Effects - target organ, alpha factor and beta factor for hazard function, and threshold dose (Sieverts)
* ORGNAM2, EFFACA, EFFACB, EFFTHR Early Fatality Effects - target organ, alpha factor and beta factor for hazard function, and threshold dose (Sieverts)
EFATAGRP001  
EFATAGRP001 'A-RED MARR' 3.8             5.0     1.5 EFATAGRP002 A-LUNGS             10.0 7.0         5.0
'A-RED MARR' 3.8 5.0 1.5 EFATAGRP002 A-LUNGS 10.0 7.0 5.0  
*
* NUMEIN - Number of Early Injury Effects EINUMEIN001 7
*
* ORGNAM3, EINAME, EISUSC, EITHRE, EIFACA, EIFACB Early Injury Effects - name, target organ, affected population fract, threshold dose, alpha factor, beta factor.
EINJUGRP001 'PRODROMAL VOMIT' A-STOMACH 1.                    .5      2.      3.
EINJUGRP002 DIARRHEA            A-STOMACH 1.              1. 3.      2.5 EINJUGRP003 PNEUMONITIS A-LUNGS                  1.      5. 10.      7.
EINJUGRP004 'SKIN ERYTHEMA'              A-SKIN 1.        3. 6.      5.
EINJUGRP005 TRANSEPIDERMAL              A-SKIN 1.        10. 20.      5.
EINJUGRP006 THYROIDITIS A-THYROIDH 1.                    40. 240. 2.
EINJUGRP007 HYPOTHYROIDISM              A-THYROIDH 1.        2.      60. 1.3
*
* NUMACA - number of latent cancer effects LCNUMACA001 7
*
* ACTHRE - dose threshold for linear dose response, Sieverts LCACTHRE001 0.0
*
* DDTHRE - dose threshold for applying dose-dependent reduction factor, DDREFA LCDDTHRE001 0.2
*
* ACNAME, ORGNAM4, ACSUSC, DOSEFA, DOSEFB, CFRISK, CIRISK, DDREFA - Latent Cancer Effects Parameters LCANCERS001 LEUKEMIA            'L-RED MARR' 1.0          1.0  0.0      9.70E-3 0.0    2.0 LCANCERS002 BONE 'L-BONE SUR' 1.0                1.0      0.0  9.00E-4 0.0      2.0 LCANCERS003 BREAST L-BREAST              1.0    1.0      0.0  5.40E-3 1.7E-2 1.0
 
NIA-089 LCANCERS004 LUNG L-LUNGS              1.0    1.0  0.0  1.55E-2 0.0    2.0 LCANCERS005 THYROID            L-THYROIDH      1.0  1.0  0.0    7.20E-4 7.2E-3 1.0 LCANCERS006 GI        'L-LOWER LI' 1.0        1.0  0.0  3.36E-2 0.0    2.0 LCANCERS007 OTHER L-EDEWBODY 1.0              1.0  0.0  2.76E-2 0.0    2.0
*
* NUM1=0 TYPE1NUMBER 0
*
* NUM1 - Number of results of type 1 TYPE1NUMBER 4
*
* NAME1, I1DIS1, I2DIS1, CCDF1 - Health-Effect Cases TYPE1OUT001 'ERL FAT/TOTAL'            1      15    NONE TYPE1OUT002 'CAN FAT/TOTAL'            1      15    NONE TYPE1OUT003 'CAN FAT/TOTAL'            1      11    NONE TYPE1OUT004 'ERL FAT/TOTAL'            1      11    NONE
*
* NUM2=0 TYPE2NUMBER 0
*
* NUM3=0 TYPE3NUMBER 0
*
* NUM4=0 TYPE4NUMBER 0
*
* NUM4 - Number of results of type 4 TYPE4NUMBER 3
*
* I1DIS4, NAME4, CCDF4 - Average Individual Risk TYPE4OUT001 1          'ERL FAT/TOTAL'        NONE TYPE4OUT002 2          'ERL FAT/TOTAL'        NONE TYPE4OUT003 3          'ERL FAT/TOTAL'        NONE
*
* NUM5 =0 TYPE5NUMBER 0
*
* NUM5 - Number of results of type 5 TYPE5NUMBER 1
*
* NAME5, I1DIS5, CCDF5 - Population Dose TYPE5OUT001 L-EDEWBODY 1              15      NONE
*
* NUM6 =0 TYPE6NUMBER 0
*
*
* NUMEIN - Number of Early Injury Effects EINUMEIN001 7
* NUM7=0 TYPE7NUMBER 0
 
NIA-089
*
*
* ORGNAM3, EINAME, EISUSC, EITHRE, EIFACA, EIFACB Early Injury Effects - name, target organ, affected population fract, threshold dose, alpha factor, beta factor. EINJUGRP001 'PRODROMAL VOMIT' A-STOMACH
* NUM8=0 TYPE8NUMBER 0
: 1. .5 2. 3. EINJUGRP002 DIARRHEA A-STOMACH
: 1. 1. 3. 2.5 EINJUGRP003 PNEUMONITIS A-LUNGS
: 1. 5. 10. 7. EINJUGRP004 'SKIN ERYTHEMA' A-SKIN
: 1. 3. 6. 5. EINJUGRP005 TRANSEPIDERMAL A-SKIN
: 1. 10. 20. 5. EINJUGRP006 THYROIDITIS A-THYROIDH
: 1. 40. 240. 2. EINJUGRP007 HYPOTHYROIDISM A-THYROIDH
: 1. 2. 60. 1.3 *
* NUMACA - number of latent cancer effects LCNUMACA001 7 *
* ACTHRE - dose threshold for linear dose response, Sieverts LCACTHRE001 0.0 *
* DDTHRE - dose threshold for applying dose-dependent reduction factor, DDREFA LCDDTHRE001 0.2
*
*
* ACNAME, ORGNAM4, ACSUSC, DOSEFA, DOSEFB, CFRISK, CIRISK, DDREFA - Latent Cancer Effects Parameters LCANCERS001 LEUKEMIA
* NUM8 - Number of results of type 8 TYPE8NUMBER 2
'L-RED MARR' 1.0 1.0 0.0 9.70E-3 0.0 2.0 LCANCERS002 BONE
'L-BONE SUR' 1.0 1.0 0.0 9.00E-4 0.0 2.0 LCANCERS003 BREAST L-BREAST 1.0 1.0 0.0 5.40E-3 1.7E-2 1.0 LCANCERS004 LUNG L-LUNGS 1.0 1.0 0.0 1.55E-2 0.0 2.0 LCANCERS005 THYROID L-THYROIDH 1.0 1.0 0.0 7.20E-4 7.2E-3 1.0 LCANCERS006 GI 'L-LOWER LI' 1.0 1.0 0.0 3.36E-2 0.0 2.0 LCANCERS007 OTHER L-EDEWBODY 1.0 1.0 0.0 2.76E-2 0.0 2.0
*
*
* NUM1=0 TYPE1NUMBER 0
* NAME8, I1DIS8, I2DIS8, CCDF8 - Population-Weighted Risk TYPE8OUT001 'ERL FAT/TOTAL'          1      3        NONE TYPE8OUT002 'CAN FAT/TOTAL'          1      11      NONE
*
*
* NUM1 - Number of results of type 1 TYPE1NUMBER 4
* NUMA=0 TYPEANUMBER 0
*
*
* NAME1, I1DIS1, I2DIS1, CCDF1 - Health-Effect Cases TYPE1OUT001 'ERL FAT/TOTAL' 1 15 NONE TYPE1OUT002 'CAN FAT/TOTAL' 1 15 NONE TYPE1OUT003 'CAN FAT/TOTAL' 1 11 NONE TYPE1OUT004 'ERL FAT/TOTAL' 1 11 NONE *
* NUMB =0 TYPEBNUMBER 0
* NUM2=0 TYPE2NUMBER 0  
*
*
* NUM3=0 TYPE3NUMBER 0
* NUMB - Number of results of type B TYPEBNUMBER 20
*
*
* NUM4=0 TYPE4NUMBER 0 *
* NAMEB, IRAD_B, IANG_B, CCDFB - Peak Dose at an (r, theta) Location TYPEBOUT001 L-EDEWBODY 1              1      NONE TYPEBOUT002 L-EDEWBODY 2              1      NONE TYPEBOUT003 L-EDEWBODY 3              1      NONE TYPEBOUT004 L-EDEWBODY 4             1      NONE TYPEBOUT005 L-EDEWBODY 5              1      NONE TYPEBOUT006 L-EDEWBODY 6              1      NONE TYPEBOUT007 L-EDEWBODY 7              1      NONE TYPEBOUT008 L-EDEWBODY 8              1      NONE TYPEBOUT009 L-EDEWBODY 9              1      NONE TYPEBOUT010 L-EDEWBODY 10            1      NONE TYPEBOUT011 L-EDEWBODY 1             9      NONE TYPEBOUT012 L-EDEWBODY 2             9      NONE TYPEBOUT013 L-EDEWBODY 3             9      NONE TYPEBOUT014 L-EDEWBODY 4              9      NONE TYPEBOUT015 L-EDEWBODY 5              9      NONE TYPEBOUT016 L-EDEWBODY 6              9      NONE TYPEBOUT017 L-EDEWBODY 7              9      NONE TYPEBOUT018 L-EDEWBODY 8              9      NONE TYPEBOUT019 L-EDEWBODY 9              9      NONE TYPEBOUT020 L-EDEWBODY 10            9      NONE
* NUM4 - Number of results of type 4 TYPE4NUMBER 3 *
* I1DIS4, NAME4, CCDF4 - Average Individual Risk TYPE4OUT001 1 'ERL FAT/TOTAL' NONE TYPE4OUT002 2 'ERL FAT/TOTAL' NONE TYPE4OUT003 3 'ERL FAT/TOTAL' NONE  
*
*
* NUM5 =0 TYPE5NUMBER 0 *
* NUMC=0 TYPECNUMBER 0
* NUM5 - Number of results of type 5 TYPE5NUMBER 1 *
* NAME5, I1DIS5, CCDF 5 - Population Dose TYPE5OUT001 L-EDEWBODY 1 15 NONE *
* NUM6 =0 TYPE6NUMBER 0 *
* NUM7=0 TYPE7NUMBER 0 
*
*
* NUM8=0 TYPE8NUMBER 0  
* NUMD = 0 TYPEDNUMBER 0
* NIA-089
* DOSMOD, dose model, LNT, AT or PL LCDOSMOD001 LNT
*
*
* NUM8 - Number of results of type 8 TYPE8NUMBER 2 *
* KIMODL, KI model EZKIMODL001 NOKI
* NAME8, I1DIS8, I2DIS8, CCDF8 - Population-Weighted Risk TYPE8OUT001 'ERL FAT/TOTAL' 1 3 NONE TYPE8OUT002 'CAN FAT/TOTAL' 1 11 NONE *
* NUMA=0 TYPEANUMBER 0
*
*
* NUMB =0 TYPEBNUMBER 0 *
* EFFACY, KI Ingestion EZEFFACY001 0.
* NUMB - Number of results of type B TYPEBNUMBER 20 *
* NAMEB, IRAD_B, IANG_B, CCDFB - Peak Dose at an (r, theta) Location TYPEBOUT001 L-EDEWBODY 1 1 NONE TYPEBOUT002 L-EDEWBODY 2 1 NONE TYPEBOUT003 L-EDEWBODY 3 1 NONE TYPEBOUT004 L-EDEWBODY 4 1 NONE TYPEBOUT005 L-EDEWBODY 5 1 NONE TYPEBOUT006 L-EDEWBODY 6 1 NONE TYPEBOUT007 L-EDEWBODY 7 1 NONE TYPEBOUT008 L-EDEWBODY 8 1 NONE TYPEBOUT009 L-EDEWBODY 9 1 NONE TYPEBOUT010 L-EDEWBODY 10 1 NONE TYPEBOUT011 L-EDEWBODY 1 9 NONE TYPEBOUT012 L-EDEWBODY 2 9 NONE TYPEBOUT013 L-EDEWBODY 3 9 NONE TYPEBOUT014 L-EDEWBODY 4 9 NONE TYPEBOUT015 L-EDEWBODY 5 9 NONE TYPEBOUT016 L-EDEWBODY 6 9 NONE TYPEBOUT017 L-EDEWBODY 7 9 NONE TYPEBOUT018 L-EDEWBODY 8 9 NONE TYPEBOUT019 L-EDEWBODY 9 9 NONE TYPEBOUT020 L-EDEWBODY 10 9 NONE *
* NUMC=0 TYPECNUMBER 0  
*
*
* NUMD = 0 TYPEDNUMBER 0 *
* POPFRAC, KI Ingestion EZPOPFRC001 0.
* DOSMOD, dose model, LNT, AT or PL LCDOSMOD001 LNT *
.}}
* KIMODL, KI model EZKIMODL001 NOKI *
* EFFACY,  KI Ingestion EZEFFACY001
: 0. *
* POPFRAC, KI Ingestion EZPOPFRC001
: 0. .}}

Revision as of 16:59, 12 November 2019

Lr Hearing - NIA-089
ML11229A081
Person / Time
Site: Indian Point  Entergy icon.png
Issue date: 10/29/2009
From:
Sandia
To:
Office of Nuclear Reactor Regulation
References
NIA-089
Download: ML11229A081 (6)
v • d • e


Text

NIA-089

  • File created using WinMACCS version 3.4.5 10/29/2009 5:21:34 PM
  • DCF_FILE - Identifies the DCF file to be used for the MACCS calculation DCF_FILE001 'f:\NBixler\WinMACCS Projects\IndianPointPalla\Data\DOSDATA.INP'
  • EANAM1 - Identifies the EARLY calculation MIEANAM1001 'EARLY.IN, IPEC INPUT FROM THE EVACUATION TIME ESTIMATES'
  • ENDAT2 - control flag allowing execution of ATMOS and EARLY without CHRONC MIENDAT2001 .FALSE.
  • IPLUME - dispersion code option MIIPLUME001 2
  • NUMFIN - number of fine-grid subdivisions used by model MINUMFIN001 7
  • IPRINT - amount of output desired MIIPRINT001 0
  • POPFLG - is population uniform or defined by Site Data File.

PDPOPFLG001 FILE

  • ORGNAM_DOSFAC, ORGFLG_DOSFAC - list of organs to be included in the calculations using DOSFAC DCF file MIORGDEF001 A-SKIN .TRUE.

MIORGDEF002 'A-RED MARR' .TRUE.

MIORGDEF003 A-LUNGS .TRUE.

MIORGDEF004 A-THYROIDH .TRUE.

MIORGDEF005 A-STOMACH .TRUE.

MIORGDEF006 'A-LOWER LI' .FALSE.

MIORGDEF007 L-EDEWBODY .TRUE.

MIORGDEF008 'L-RED MARR' .TRUE.

MIORGDEF009 'L-BONE SUR' .TRUE.

MIORGDEF010 L-BREAST .TRUE.

MIORGDEF011 L-LUNGS .TRUE.

MIORGDEF012 L-THYROID .TRUE.

MIORGDEF013 'L-LOWER LI' .TRUE.

MIORGDEF014 'L-BLAD WAL' .TRUE.

MIORGDEF015 L-LIVER .FALSE.

MIORGDEF016 L-THYROIDH .TRUE.

  • RISCAT - Output relative contribution of each weather category bins MIRISCAT001 .FALSE.
  • OVRRID - Flag indicating if Wind Rose defaults from ATMOS are to be overridden MIOVRRID001 .FALSE.
  • NIA-089
  • CSFACT - Cloudshine shielding factor SECSFACT001 1.

SECSFACT002 0.75 SECSFACT003 0.6

  • PROTIN - Inhalation protection factor SEPROTIN001 1.

SEPROTIN002 0.41 SEPROTIN003 0.33

  • BRRATE - Breathing rates SEBRRATE001 2.66E-4 SEBRRATE002 2.66E-4 SEBRRATE003 2.66E-4
  • SKPFAC - skin protection factors SESKPFAC001 1.0 SESKPFAC002 0.41 SESKPFAC003 0.33
  • GSHFAC - groundshine shielding factors SEGSHFAC001 0.5 SEGSHFAC002 0.4 SEGSHFAC003 0.2
  • RESCON - Initial value for emergency-phase resuspension concentration factor.

SERESCON001 1.E-4

  • RESHAF - Emergency-phase resuspension concentration coefficient weathering half-life.

SERESHAF001 1.82E5

  • EANAM2 - Name of emergency response scenario EZEANAM2001 'NO EVACUATION, RELOCATION MODELS APPLY EVERYWHE'
  • WTNAME - type of weighting factor to be used in generating weighted sum of results EZWTNAME001 PEOPLE
  • WTFRAC - weighting fraction applied to results of emergency response scenario EZWTFRAC001 1.00
  • LASMOV2 (used for no evacuation), always 0 EZLASMOV001 0
  • ENDEMP - duration of the emergency-phase period, seconds SRENDEMP001 604800.
  • CRIORG - critical organ for relocation decisions during emergency-phase period SRCRIORG001 L-EDEWBODY

NIA-089

  • TIMHOT - hot-spot relocation action time, seconds after plume arrival SRTIMHOT001 43200.
  • TIMNRM - Normal Relocation Time (Seconds from Plume Arrival)

SRTIMNRM001 86400.

  • DOSHOT - Hot-Spot Relocation Dose Threshold (Sieverts)

SRDOSHOT001 0.5

  • DOSNRM - Normal Relocation Dose Threshold (Sieverts)

SRDOSNRM001 0.25

  • NUMEFA - Number of Early Fatality Effects EFNUMEFA001 2
  • ORGNAM2, EFFACA, EFFACB, EFFTHR Early Fatality Effects - target organ, alpha factor and beta factor for hazard function, and threshold dose (Sieverts)

EFATAGRP001 'A-RED MARR' 3.8 5.0 1.5 EFATAGRP002 A-LUNGS 10.0 7.0 5.0

  • NUMEIN - Number of Early Injury Effects EINUMEIN001 7
  • ORGNAM3, EINAME, EISUSC, EITHRE, EIFACA, EIFACB Early Injury Effects - name, target organ, affected population fract, threshold dose, alpha factor, beta factor.

EINJUGRP001 'PRODROMAL VOMIT' A-STOMACH 1. .5 2. 3.

EINJUGRP002 DIARRHEA A-STOMACH 1. 1. 3. 2.5 EINJUGRP003 PNEUMONITIS A-LUNGS 1. 5. 10. 7.

EINJUGRP004 'SKIN ERYTHEMA' A-SKIN 1. 3. 6. 5.

EINJUGRP005 TRANSEPIDERMAL A-SKIN 1. 10. 20. 5.

EINJUGRP006 THYROIDITIS A-THYROIDH 1. 40. 240. 2.

EINJUGRP007 HYPOTHYROIDISM A-THYROIDH 1. 2. 60. 1.3

  • NUMACA - number of latent cancer effects LCNUMACA001 7
  • ACTHRE - dose threshold for linear dose response, Sieverts LCACTHRE001 0.0
  • DDTHRE - dose threshold for applying dose-dependent reduction factor, DDREFA LCDDTHRE001 0.2
  • ACNAME, ORGNAM4, ACSUSC, DOSEFA, DOSEFB, CFRISK, CIRISK, DDREFA - Latent Cancer Effects Parameters LCANCERS001 LEUKEMIA 'L-RED MARR' 1.0 1.0 0.0 9.70E-3 0.0 2.0 LCANCERS002 BONE 'L-BONE SUR' 1.0 1.0 0.0 9.00E-4 0.0 2.0 LCANCERS003 BREAST L-BREAST 1.0 1.0 0.0 5.40E-3 1.7E-2 1.0

NIA-089 LCANCERS004 LUNG L-LUNGS 1.0 1.0 0.0 1.55E-2 0.0 2.0 LCANCERS005 THYROID L-THYROIDH 1.0 1.0 0.0 7.20E-4 7.2E-3 1.0 LCANCERS006 GI 'L-LOWER LI' 1.0 1.0 0.0 3.36E-2 0.0 2.0 LCANCERS007 OTHER L-EDEWBODY 1.0 1.0 0.0 2.76E-2 0.0 2.0

  • NUM1=0 TYPE1NUMBER 0
  • NUM1 - Number of results of type 1 TYPE1NUMBER 4
  • NAME1, I1DIS1, I2DIS1, CCDF1 - Health-Effect Cases TYPE1OUT001 'ERL FAT/TOTAL' 1 15 NONE TYPE1OUT002 'CAN FAT/TOTAL' 1 15 NONE TYPE1OUT003 'CAN FAT/TOTAL' 1 11 NONE TYPE1OUT004 'ERL FAT/TOTAL' 1 11 NONE
  • NUM2=0 TYPE2NUMBER 0
  • NUM3=0 TYPE3NUMBER 0
  • NUM4=0 TYPE4NUMBER 0
  • NUM4 - Number of results of type 4 TYPE4NUMBER 3
  • I1DIS4, NAME4, CCDF4 - Average Individual Risk TYPE4OUT001 1 'ERL FAT/TOTAL' NONE TYPE4OUT002 2 'ERL FAT/TOTAL' NONE TYPE4OUT003 3 'ERL FAT/TOTAL' NONE
  • NUM5 =0 TYPE5NUMBER 0
  • NUM5 - Number of results of type 5 TYPE5NUMBER 1
  • NAME5, I1DIS5, CCDF5 - Population Dose TYPE5OUT001 L-EDEWBODY 1 15 NONE
  • NUM6 =0 TYPE6NUMBER 0
  • NUM7=0 TYPE7NUMBER 0

NIA-089

  • NUM8=0 TYPE8NUMBER 0
  • NUM8 - Number of results of type 8 TYPE8NUMBER 2
  • NAME8, I1DIS8, I2DIS8, CCDF8 - Population-Weighted Risk TYPE8OUT001 'ERL FAT/TOTAL' 1 3 NONE TYPE8OUT002 'CAN FAT/TOTAL' 1 11 NONE
  • NUMA=0 TYPEANUMBER 0
  • NUMB =0 TYPEBNUMBER 0
  • NUMB - Number of results of type B TYPEBNUMBER 20
  • NAMEB, IRAD_B, IANG_B, CCDFB - Peak Dose at an (r, theta) Location TYPEBOUT001 L-EDEWBODY 1 1 NONE TYPEBOUT002 L-EDEWBODY 2 1 NONE TYPEBOUT003 L-EDEWBODY 3 1 NONE TYPEBOUT004 L-EDEWBODY 4 1 NONE TYPEBOUT005 L-EDEWBODY 5 1 NONE TYPEBOUT006 L-EDEWBODY 6 1 NONE TYPEBOUT007 L-EDEWBODY 7 1 NONE TYPEBOUT008 L-EDEWBODY 8 1 NONE TYPEBOUT009 L-EDEWBODY 9 1 NONE TYPEBOUT010 L-EDEWBODY 10 1 NONE TYPEBOUT011 L-EDEWBODY 1 9 NONE TYPEBOUT012 L-EDEWBODY 2 9 NONE TYPEBOUT013 L-EDEWBODY 3 9 NONE TYPEBOUT014 L-EDEWBODY 4 9 NONE TYPEBOUT015 L-EDEWBODY 5 9 NONE TYPEBOUT016 L-EDEWBODY 6 9 NONE TYPEBOUT017 L-EDEWBODY 7 9 NONE TYPEBOUT018 L-EDEWBODY 8 9 NONE TYPEBOUT019 L-EDEWBODY 9 9 NONE TYPEBOUT020 L-EDEWBODY 10 9 NONE
  • NUMC=0 TYPECNUMBER 0
  • NUMD = 0 TYPEDNUMBER 0
  • NIA-089
  • DOSMOD, dose model, LNT, AT or PL LCDOSMOD001 LNT
  • KIMODL, KI model EZKIMODL001 NOKI
  • EFFACY, KI Ingestion EZEFFACY001 0.
  • POPFRAC, KI Ingestion EZPOPFRC001 0.

.

Retrieved from "https://kanterella.com/w/index.php?title=ML11229A081&oldid=2114018"